Skip to Main content Skip to Navigation
Book sections

Translational approach to radiopharmaceutical development

Latifa Rbah-Vidal 1 Pedro Fragoso Costa 2, 3 
1 CRCINA-ÉQUIPE 13 - Nuclear Oncology
CRCINA - Centre de Recherche en Cancérologie et Immunologie Nantes-Angers
Abstract : Nuclear medicine, which encompasses the medical field of molecular imaging and radionuclide therapy, brings together many disciplines, and radiopharmacy requires that pharmacy, physics and medicine work together within a synergetic environment. It is undeniable that within nuclear medicine the baseline of any good procedure is the design and preparation of the radioactive pharmaceutical, referred to as the radiopharmaceutical.
Document type :
Book sections
Complete list of metadata

https://www.hal.inserm.fr/inserm-03295505
Contributor : Latifa Rbah-Vidal Connect in order to contact the contributor
Submitted on : Thursday, July 22, 2021 - 10:49:33 AM
Last modification on : Wednesday, April 27, 2022 - 4:23:04 AM
Long-term archiving on: : Saturday, October 23, 2021 - 6:16:43 PM

File

EANM19_TechGuide-Chap11.pdf
Files produced by the author(s)

Identifiers

  • HAL Id : inserm-03295505, version 1

Citation

Latifa Rbah-Vidal, Pedro Fragoso Costa. Translational approach to radiopharmaceutical development. Radiopharmacy: An update, chapter 11, European Association of Nuclear Medicine, pp.138-149, 2019. ⟨inserm-03295505⟩

Share

Metrics

Record views

38

Files downloads

64